ACADIA PHARMACEUTICALS INC — Director's Dealing 2012

Aug 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2012-08-03

Reporting Person: Aasen Thomas H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-03	Common Stock	M	5000	$1.50	Acquired	54602	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-03	Stock Option (right to buy)	$1.50	M	5000	Disposed	2012-09-08	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1369	Indirect

Footnotes

F1: Includes an aggregate of 39,936 shares acquired by Mr. Aasen under the ACADIA Pharmaceuticals Employee Stock Puchase Plan since inception.

F2: Number reflects 965 shares gifted by The Aasen Family Trust on December 18, 2007, but incorrectly attributed to direct holdings of Mr. Aasen.